Efavirenz Conceptions and Regimen Management in a Prospective Cohort of Women on Antiretroviral Therapy

Use of the antiretroviral drug efavirenz (EFV) is not recommended by the WHO or South African HIV treatment guidelines during the first trimester of pregnancy due to potential fetal teratogenicity; there is little evidence of how clinicians manage EFV-related fertility concerns. Women on antiretrovi...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwartz, Sheree, Taha, Taha E., Venter, Willem Daniel Francois, Mehta, Shruti, Rees, Helen, Black, Vivian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3384948/
https://www.ncbi.nlm.nih.gov/pubmed/22778534
http://dx.doi.org/10.1155/2012/723096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3384948/
https://www.ncbi.nlm.nih.gov/pubmed/22778534
http://dx.doi.org/10.1155/2012/723096

Ejemplares similares